Chen Y, Chou C, Er T
Biomedicines. 2024; 12(4).
PMID: 38672149
PMC: 11048335.
DOI: 10.3390/biomedicines12040791.
Seropian I, Cassaglia P, Miksztowicz V, Gonzalez G
Front Physiol. 2024; 14:1304735.
PMID: 38170009
PMC: 10759241.
DOI: 10.3389/fphys.2023.1304735.
Zaborska B, Sikora-Frac M, Smarz K, Pilichowska-Paszkiet E, Budaj A, Sitkiewicz D
Int J Mol Sci. 2023; 24(17).
PMID: 37685918
PMC: 10488150.
DOI: 10.3390/ijms241713111.
Wang X, Gaur M, Mounzih K, Rodriguez H, Qiu H, Chen M
Cardiovasc Res. 2023; 119(15):2536-2549.
PMID: 37602717
PMC: 10676456.
DOI: 10.1093/cvr/cvad116.
Bosnjak I, Bedekovic D, Selthofer-Relatic K, Roguljic H, Mihaljevic I, Bilic-Curcic I
BMC Cardiovasc Disord. 2023; 23(1):268.
PMID: 37221462
PMC: 10204313.
DOI: 10.1186/s12872-023-03310-y.
A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia.
Ghorbanpour S, Richards C, Pienaar D, Sesperez K, Aboulkheyr Es H, Nikolic V
Cell Mol Life Sci. 2023; 80(2):44.
PMID: 36652019
PMC: 9849194.
DOI: 10.1007/s00018-022-04648-w.
The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease.
Mansour A, Krautter F, Zhi Z, Iqbal A, Recio C
Cardiovasc Diabetol. 2022; 21(1):253.
PMID: 36403025
PMC: 9675972.
DOI: 10.1186/s12933-022-01690-7.
Association between Endothelial Cell-Specific Molecule 1 and Galectin-3 in Patients with ST-Segment Elevation Myocardial Infarction: A Pilot Study.
Wei P, Wang X, Fu Q, Zong B, Liu X, Zhang M
Oxid Med Cell Longev. 2022; 2022:1723309.
PMID: 36388167
PMC: 9646309.
DOI: 10.1155/2022/1723309.
Levels of Galectin-3 in Chronic Heart Failure: A Case-Control Study.
Khadeja Bi A, Santhosh V, Sigamani K
Cureus. 2022; 14(8):e28310.
PMID: 36158385
PMC: 9499328.
DOI: 10.7759/cureus.28310.
Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis.
Cheng Z, Cai K, Xu C, Zhan Q, Xu X, Xu D
Front Cardiovasc Med. 2022; 9:783707.
PMID: 35252382
PMC: 8894589.
DOI: 10.3389/fcvm.2022.783707.
Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study.
Chen Y, Fu W, Zheng Y, Yang J, Liu Y, Qi Z
Eur Heart J. 2022; 43(37):3556-3574.
PMID: 35165707
PMC: 9989600.
DOI: 10.1093/eurheartj/ehac034.
Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.
Tilea I, Varga A, Serban R
Diagnostics (Basel). 2021; 11(5).
PMID: 34063483
PMC: 8156776.
DOI: 10.3390/diagnostics11050881.
The stress hyperglycaemia ratio is associated with left ventricular remodelling after first acute ST-segment elevation myocardial infarction.
Meng S, Zhu Y, Liu K, Jia R, Nan J, Chen M
BMC Cardiovasc Disord. 2021; 21(1):72.
PMID: 33541271
PMC: 7863236.
DOI: 10.1186/s12872-021-01889-8.
Galectin-3 in Cardiovascular Diseases.
Blanda V, Bracale U, di Taranto M, Fortunato G
Int J Mol Sci. 2020; 21(23).
PMID: 33287402
PMC: 7731136.
DOI: 10.3390/ijms21239232.
MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1.
Li X, Zhang S, Wa M, Liu Z, Hu S
J Am Heart Assoc. 2019; 8(23):e013112.
PMID: 31766975
PMC: 6912979.
DOI: 10.1161/JAHA.119.013112.
Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
Tyminska A, Kaplon-Cieslicka A, Ozieranski K, Budnik M, Wancerz A, Sypien P
Dis Markers. 2019; 2019:9529053.
PMID: 31687050
PMC: 6811795.
DOI: 10.1155/2019/9529053.
Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction.
Andrejic O, Vucic R, Pavlovic M, McClements L, Stokanovic D, Jevtovic-Stoimenov T
Sci Rep. 2019; 9(1):13145.
PMID: 31511537
PMC: 6739356.
DOI: 10.1038/s41598-019-49511-4.
Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study.
Djordjevic A, Dekleva M, Zivkovic M, Stankovic A, Markovic Nikolic N, Alavantic D
Mol Biol Rep. 2018; 45(6):2227-2236.
PMID: 30229476
DOI: 10.1007/s11033-018-4384-4.
Ticagrelor attenuates myocardial ischaemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats.
Liu X, Gu Y, Liu Y, Zhang M, Wang Y, Hu L
Br J Clin Pharmacol. 2018; 84(6):1180-1186.
PMID: 29381821
PMC: 5980592.
DOI: 10.1111/bcp.13536.
Critical effects of long non-coding RNA on fibrosis diseases.
Zhang Y, Luo G, Zhang Y, Zhang M, Zhou J, Gao W
Exp Mol Med. 2018; 50(1):e428.
PMID: 29350677
PMC: 5799794.
DOI: 10.1038/emm.2017.223.
